Literature DB >> 1713663

CSF and blood pharmacokinetics of hydromorphone and morphine following lumbar epidural administration.

William G Brose1, Darrell L Tanelian, Jay B Brodsky, James B D Mark, Michael J Cousins.   

Abstract

Sixteen consenting patients scheduled for elective thoracotomy were enrolled into a randomized trial of epidural morphine and hydromorphone. Each patient had a lumbar epidural catheter placed preoperatively for the purpose of post-thoracotomy analgesia. Shortly before the end of the operative procedure each patient received 5 mg of morphine and 0.75 mg of hydromorphone via the epidural catheter. Blood was sampled at regular intervals following the opiate administration and patients were randomized to 1 of 7 cervical CSF sampling times. Blood and CSF samples were assayed for morphine and hydromorphone concentration to determine blood and CSF pharmacokinetic profiles. A maximum blood morphine concentration of 60 +/- 25 ng/ml (mean +/- S.D.) was obtained at 11 +/- 6 min (mean +/- S.D.). The blood hydromorphone peak of 14 +/- 13 ng/ml (mean +/- S.D.) occurred 8 +/- 6 min (mean +/- S.D.). The mean peak CSF opioid concentrations of 1581 ng/ml for morphine and 309 ng/ml for hydromorphone occurred 60 min after epidural administration. The blood and CSF pharmacokinetic profiles for morphine and hydromorphone are presented. These profiles are similar for the two drugs after lumbar epidural administration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713663     DOI: 10.1016/0304-3959(91)90158-T

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  11 in total

1.  Hydromorphone: a cost-effective alternative to the use of oxymorphone.

Authors:  G Pettifer; D Dyson
Journal:  Can Vet J       Date:  2000-02       Impact factor: 1.008

Review 2.  Pathophysiology of opioid tolerance and clinical approach to the opioid-tolerant patient.

Authors:  O de Leon-Casasola; A Yarussi
Journal:  Curr Rev Pain       Date:  2000

3.  Epidural morphine vs hydromorphone in post-caesarean section patients.

Authors:  S H Halpern; R Arellano; R Preston; J Carstoniu; G O'Leary; S Roger; A Sandler
Journal:  Can J Anaesth       Date:  1996-06       Impact factor: 5.063

4.  Complications of spinal opioid therapy: myoclonus, spastic muscle tone and spinal jerking.

Authors:  M Kloke; U Bingel; S Seeber
Journal:  Support Care Cancer       Date:  1994-07       Impact factor: 3.603

Review 5.  Opioid analgesics: comparative features and prescribing guidelines.

Authors:  N I Cherny
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

6.  [Drug therapy for tumor pain I. Properties of non-opioids and opioids.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1994-12       Impact factor: 1.107

7.  [Pharmacotherapy of cancer pain : 2. Use of opioids.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1995-01       Impact factor: 1.107

8.  Intra-operative epidural morphine, fentanyl, and droperidol for control of pain after spinal surgery. A prospective, randomized, placebo-controlled, and double-blind trial.

Authors:  N G Rainov; T Gutjahr; W Burkert
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

9.  Pain Challenges at the End of Life - Pain and Palliative Care Collaboration.

Authors:  Michael Platt
Journal:  Rev Pain       Date:  2010-10

10.  Single dose epidural hydromorphone in labour pain: maternal pharmacokinetics and neonatal exposure.

Authors:  Terhi Puhto; Merja Kokki; Henriikka Hakomäki; Michael Spalding; Teemu Gunnar; Seppo Alahuhta; Merja Vakkala
Journal:  Eur J Clin Pharmacol       Date:  2020-05-03       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.